ATE110109T1 - Monoklonaler antikörper gegen kern-hcg-beta, seine herstellung und verwendung. - Google Patents

Monoklonaler antikörper gegen kern-hcg-beta, seine herstellung und verwendung.

Info

Publication number
ATE110109T1
ATE110109T1 AT90118991T AT90118991T ATE110109T1 AT E110109 T1 ATE110109 T1 AT E110109T1 AT 90118991 T AT90118991 T AT 90118991T AT 90118991 T AT90118991 T AT 90118991T AT E110109 T1 ATE110109 T1 AT E110109T1
Authority
AT
Austria
Prior art keywords
monoclonal antibody
hcg
beta
production
core
Prior art date
Application number
AT90118991T
Other languages
English (en)
Inventor
Kiyoshi Kobayashi
Makoto Katsuno
Takahisa Kobayashi
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE110109T1 publication Critical patent/ATE110109T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90118991T 1989-10-04 1990-10-04 Monoklonaler antikörper gegen kern-hcg-beta, seine herstellung und verwendung. ATE110109T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP25929389 1989-10-04

Publications (1)

Publication Number Publication Date
ATE110109T1 true ATE110109T1 (de) 1994-09-15

Family

ID=17332067

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90118991T ATE110109T1 (de) 1989-10-04 1990-10-04 Monoklonaler antikörper gegen kern-hcg-beta, seine herstellung und verwendung.

Country Status (6)

Country Link
US (1) US5501988A (de)
EP (1) EP0421392B1 (de)
AT (1) ATE110109T1 (de)
CA (1) CA2025266A1 (de)
DE (1) DE69011613T2 (de)
ES (1) ES2057307T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674983A (en) * 1989-01-03 1997-10-07 The United States Of America As Represented By The Department Of Health And Human Services Natural human chorionic gonadotropin β-core molecule
DE69328831T2 (de) * 1992-03-24 2001-01-11 Allegheny-Singer Research Institute, Pittsburgh Methoden der anwendung von antikörpern gegen humane chorionic gonadotropin verwandte determinanten zur lyse von kranken zellen
US6025149A (en) * 1995-07-07 2000-02-15 Yale University Urinary screening for down syndrome and other aneuploidies
US5716853A (en) * 1995-07-07 1998-02-10 Chiron Diagnostics Corporation Prenatal down syndrome screening with assays specific for UGP
US6821738B2 (en) * 1999-01-20 2004-11-23 The Board Of Regents For Oklahoma State University Broad spectrum bio-detection of nerve agents, organophosphates, and other chemical warfare agents
US7994278B1 (en) * 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US20020199218A1 (en) * 1999-08-19 2002-12-26 Daphne Goring Proline-rich extensin-like receptor kinases
CA2364983A1 (en) * 2000-12-13 2002-06-13 John R. Coleman Nucleic acid molecules and polypeptides for catabolism of abscisic acid
US7556807B2 (en) 2001-02-20 2009-07-07 Kane Biotech, Inc. Signal peptides, nucleic acid molecules and methods for treatment of caries
US7597895B2 (en) * 2001-02-20 2009-10-06 The Governing Council Of The University Of Toronto Signal peptides, nucleic acid molecules and methods for treatment of caries
WO2005095458A1 (en) * 2004-04-02 2005-10-13 The Talwar Research Foundation CHIMERIC MONOCLONAL ANTIBODY FOR BINDING WITH HIGH AFFINITY SELECTIVELY TO hCG
EP1802645A4 (de) * 2004-09-27 2009-01-14 Cornell Res Foundation Inc Rekombinantes bifunktionelles protein aus einem rezeptor für menschliches lutropin sowie menschliche chorion-gonadotropin-b-untereinheit und deren verwendungen
EP2445932B1 (de) 2009-06-26 2018-02-28 Soricimed Biopharma Inc. Soriciden-abgeleitete peptide und verfahren zum nachweisen von trpv-6-krebsarten und medikamentenverabreichung

Also Published As

Publication number Publication date
EP0421392A1 (de) 1991-04-10
US5501988A (en) 1996-03-26
DE69011613D1 (de) 1994-09-22
CA2025266A1 (en) 1991-04-05
DE69011613T2 (de) 1995-01-26
ES2057307T3 (es) 1994-10-16
EP0421392B1 (de) 1994-08-17

Similar Documents

Publication Publication Date Title
KR880006357A (ko) 인터류킨-i에 대한 항체
DE69011613D1 (de) Monoklonaler Antikörper gegen Kern-hCG-beta, seine Herstellung und Verwendung.
DE69630313D1 (de) Mit monoklonalem antikörper anti-her2 induzierte apoptosis
DE68913402D1 (de) Antikörper mit hoher Affinität für Methamphetamine sowie geeignetes Immunogen für seine Herstellung.
DE3170352D1 (en) Hybrid cell line for producing monoclonal antibody to a human t cell antigen, antibody, and methods
ATE14023T1 (de) Einen monoklonalen antikoerper produzierende hybridzellinie, antikoerper und verfahren zu seiner herstellung, diesen antikoerper enthaltende therapeutische zusammensetzung und deren diagnostische und therapeutische verwendungen.
SE9102074D0 (sv) Tomour antigen specific antibody
JPS5695121A (en) Hybrid cell line* antibody and method of manufacturing complementtfixing monoclonal antibody to human suppressor t cell
ATE14899T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches monozytantigen, antikoerper und verfahren.
EP0344134A3 (en) Monoclonal antibody specific to a fibronectin sequence expressed in transformed cells, hybridoma secreting said antibody and use of said monoclonal antibody in the diagnosis of tumors
AU545181B2 (en) Hybridoma for producing monoclonal antibodies
EP0161638A3 (en) Monoclonal antibody and method for quantitation of immoglobulins using the same
YU306680A (en) Method of obtaining monoclonal antibodies
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
ATE283927T1 (de) Monoklonale antikörper und antigene mit bezug zum menschlichen lungenadenokarzinom und immunoassay- verfahren unter verwendung desselben
ATE116004T1 (de) Antikörper gegen menschliches sperma, ihre herstellung und anwendung.
ATE87941T1 (de) Monoklonaler antikoerper gegen ein p21-bezuegliches dodekapeptid des ras-onkogens.
DE3885975D1 (de) Monoklonale Antikörper gegen menschliche alpha-Atrialnatriüretic-Polypeptide und entsprechende Hybridome, deren Herstellung und Verwendung.
DE3783002D1 (de) Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega.
EP0328248A3 (de) Monoklonale Antikörper gegen Follikelstimulierendes Hormon
ATE103973T1 (de) Gamma-atriales, natriuretisches polypeptid erkennende monoklonale antikoerper, solche antikoerper produzierende hybridome und deren herstellung und verwendung.
ATE114333T1 (de) Monoklonaler antikörper gegen endothelin, zu dessen herstellung fähiges hybridom und radioimmuntest für endothelin unter verwendung desselben.
EP0119859A3 (de) Monoklonale Antikörper, Verfahren zu ihrer Herstellung und Methoden für ihre Verwendung
JPS6427491A (en) Monoclonal antibody
EP0190049A3 (en) Method for selecting hybridomas producing antibodies specific to inaccessible cell surface antigens

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties